Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinicopathologic reports, case reports, and small case series: surgical removal and histopathologic findings of a subfoveal neovascular membrane associated with choroidal osteoma.

× No keyword cloud information.

16 in total

1. [Newly occurring loss of visual acuity in choroidal osteoma].

Authors: A Schuh; P Foerster; S Priglinger; K Eibl-Lindner
Journal: Ophthalmologe Date: 2018-03 Impact factor: 1.059

2. Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin).

Authors: Hamid Ahmadieh; Nasser Vafi
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2007-07-25 Impact factor: 3.117

3. Intravitreal bevacizumab monotherapy for choroidal neovascularisation secondary to choroidal osteoma.

Authors: V P Papastefanou; M Pefkianaki; L Al Harby; A K Arora; V M L Cohen; R M Andrews; M S Sagoo
Journal: Eye (Lond) Date: 2016-04-01 Impact factor: 3.775

4. Secondary choroidal neovascularization due to choroidal osteoma after 9 years follow-up.

Authors: Yun Zhang; Jia Fang; Shixin Zhao; Xiangjun She; Jun Wang; Lijun Shen
Journal: BMC Ophthalmol Date: 2021-05-31 Impact factor: 2.209

5. Long-term success of intravitreal bevacizumab for choroidal neovascularization associated with choroidal osteoma.

Authors: Mariko Kubota-Taniai; Toshiyuki Oshitari; Maya Handa; Takayuki Baba; Jiro Yotsukura; Shuichi Yamamoto
Journal: Clin Ophthalmol Date: 2011-07-27

6. Long-term outcomes of intravitreal injection of bevacizumab for choroidal neovascularization associated with choroidal osteoma.

Authors: Tadanobu Yoshikawa; Kanji Takahashi
Journal: Clin Ophthalmol Date: 2015-03-03

Clinicopathologic reports, case reports, and small case series: surgical removal and histopathologic findings of a subfoveal neovascular membrane associated with choroidal osteoma.

1. [Newly occurring loss of visual acuity in choroidal osteoma].

2. Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin).

3. Intravitreal bevacizumab monotherapy for choroidal neovascularisation secondary to choroidal osteoma.

4. Secondary choroidal neovascularization due to choroidal osteoma after 9 years follow-up.

5. Long-term success of intravitreal bevacizumab for choroidal neovascularization associated with choroidal osteoma.

6. Long-term outcomes of intravitreal injection of bevacizumab for choroidal neovascularization associated with choroidal osteoma.

7. Long-term results of intravitreal ranibizumab for osteoma-related choroidal neovascularization in a child.

8. Choroidal osteoma: the varied response of subretinal fluid to anti-VEGF agents.

9. Bilateral Multifocal Choroidal Osteoma with Choroidal Neovascularization.

10. Bilateral choroidal osteoma with choroidal neovascular membrane treated with bevacizumab in a child.